Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus (HIV). In the current study, we used the mous...

詳細記述

書誌詳細

出版年:	Viruses
主要な著者:	Jiafen Hu, Sarah A. Brendle, Jingwei J. Li, Vonn Walter, Nancy M. Cladel, Timothy Cooper, Debra A. Shearer, Karla K. Balogh, Neil D. Christensen
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-05-01
主題:	contraceptive progesterone Depo-Provera DMPA 17β-estradiol lower genital tract
オンライン･アクセス:	https://www.mdpi.com/1999-4915/14/5/980